Just 0.2% of tests have come back positive for the influenza virus, a remarkably low positivity rate for this time of the year, according to the CDC.
The FDA expanded the approved indication for Genetech’s Xofluza (baloxavir marboxil) to include post-exposure prevention of influenza for patients 12 years of age and older after contact with an individual who has the flu.Read More
The rate of people seeking medical care for flu-like symptoms saw a small uptick this past week, but laboratory-confirmed flu cases remain low, according to recent data from the CDC.Read More
Flu cases have remained low in recent weeks with influenza A surfacing as the dominant strain in the first days of this year’s flu season.Read More
Health officials have reported the first case of someone testing positive for both COVID-19 and the flu in California, according to local news reports.Read More
A study published online as an accepted paper in the Journal of Clinical Sleep Medicine is finds that patients with sleep apnea who did not use CPAP therapy were more likely to be hospitalized with the flu.Read More
While flu activity throughout the country remains low, the CDC suggests that everyone 6 months and older get a flu vaccine before the end of October.Read More
A vaccine candidate that triggers an immune response against the hemagglutinin protein may help lead to a universal flu vaccine.Read More